Loading...

TTK Healthcare

NSEI:TTKHEALTH
Snowflake Description

Flawless balance sheet average dividend payer.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
TTKHEALTH
NSEI
₹10B
Market Cap
  1. Home
  2. IN
  3. Pharmaceuticals & Biotech
Company description

TTK Healthcare Limited engages in the pharmaceuticals, consumer products, medical devices, and food businesses primarily in India. The last earnings update was 81 days ago. More info.


Add to Portfolio Compare Print
  • TTK Healthcare has significant price volatility in the past 3 months.
TTKHEALTH Share Price and Events
7 Day Returns
-1.8%
NSEI:TTKHEALTH
-0%
IN Pharmaceuticals
0.8%
IN Market
1 Year Returns
-36.1%
NSEI:TTKHEALTH
1%
IN Pharmaceuticals
-0.7%
IN Market
TTKHEALTH Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
TTK Healthcare (TTKHEALTH) -1.8% 0.2% -11.5% -36.1% -29.1% 32.9%
IN Pharmaceuticals -0% 0.8% 4.2% 1% -11.1% 36.2%
IN Market 0.8% 2.1% 5.8% -0.7% 41.2% 72.5%
1 Year Return vs Industry and Market
  • TTKHEALTH underperformed the Pharmaceuticals industry which returned 1% over the past year.
  • TTKHEALTH underperformed the Market in India which returned -0.7% over the past year.
Price Volatility
TTKHEALTH
Industry
5yr Volatility vs Market

TTKHEALTH Value

 Is TTK Healthcare undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of TTK Healthcare to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for TTK Healthcare.

NSEI:TTKHEALTH Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 14.7%
Perpetual Growth Rate 10-Year IN Government Bond Rate 7.6%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NSEI:TTKHEALTH
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year IN Govt Bond Rate 7.6%
Equity Risk Premium S&P Global 8.6%
Pharmaceuticals Unlevered Beta Simply Wall St/ S&P Global 0.73
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.729 (1 + (1- 35%) (3.05%))
0.828
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.83
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 7.55% + (0.828 * 8.6%)
14.67%

Discounted Cash Flow Calculation for NSEI:TTKHEALTH using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for TTK Healthcare is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

NSEI:TTKHEALTH DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (INR, Millions) Source Present Value
Discounted (@ 14.67%)
2019 164.19 Est @ 11.66% 143.18
2020 181.30 Est @ 10.43% 137.88
2021 198.64 Est @ 9.56% 131.74
2022 216.44 Est @ 8.96% 125.18
2023 234.92 Est @ 8.54% 118.49
2024 254.27 Est @ 8.24% 111.84
2025 274.70 Est @ 8.03% 105.37
2026 296.37 Est @ 7.89% 99.14
2027 319.45 Est @ 7.79% 93.19
2028 344.10 Est @ 7.72% 87.54
Present value of next 10 years cash flows ₹1,153.56
NSEI:TTKHEALTH DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= ₹344.10 × (1 + 7.55%) ÷ (14.67% – 7.55%)
₹5,198.00
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= ₹5,198.00 ÷ (1 + 14.67%)10
₹1,322.37
NSEI:TTKHEALTH Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= ₹1,153.56 + ₹1,322.37
₹2,475.93
Equity Value per Share
(INR)
= Total value / Shares Outstanding
= ₹2,475.93 / 14.13
₹175.22
NSEI:TTKHEALTH Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in NSEI:TTKHEALTH represents 0.99736x of BSE:507747
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.99736x
Value per Share
(Listing Adjusted, INR)
= Value per Share (INR) x Listing Adjustment Factor
= ₹ 175.22 x 0.99736
₹174.76
Value per share (INR) From above. ₹174.76
Current discount Discount to share price of ₹680.20
= -1 x (₹680.20 - ₹174.76) / ₹174.76
-289.2%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of TTK Healthcare is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for TTK Healthcare's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are TTK Healthcare's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NSEI:TTKHEALTH PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in INR ₹14.50
BSE:507747 Share Price ** BSE (2019-04-18) in INR ₹682
India Pharmaceuticals Industry PE Ratio Median Figure of 112 Publicly-Listed Pharmaceuticals Companies 20.2x
India Market PE Ratio Median Figure of 2,738 Publicly-Listed Companies 16.33x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of TTK Healthcare.

NSEI:TTKHEALTH PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= BSE:507747 Share Price ÷ EPS (both in INR)

= 682 ÷ 14.50

47.04x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • TTK Healthcare is overvalued based on earnings compared to the IN Pharmaceuticals industry average.
  • TTK Healthcare is overvalued based on earnings compared to the India market.
Price based on expected Growth
Does TTK Healthcare's expected growth come at a high price?
Raw Data
NSEI:TTKHEALTH PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 47.04x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
6.7%per year
India Pharmaceuticals Industry PEG Ratio Median Figure of 32 Publicly-Listed Pharmaceuticals Companies 1.39x
India Market PEG Ratio Median Figure of 585 Publicly-Listed Companies 1.32x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for TTK Healthcare, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on TTK Healthcare's assets?
Raw Data
NSEI:TTKHEALTH PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in INR ₹169.26
BSE:507747 Share Price * BSE (2019-04-18) in INR ₹682
India Pharmaceuticals Industry PB Ratio Median Figure of 133 Publicly-Listed Pharmaceuticals Companies 1.88x
India Market PB Ratio Median Figure of 3,628 Publicly-Listed Companies 1.11x
NSEI:TTKHEALTH PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= BSE:507747 Share Price ÷ Book Value per Share (both in INR)

= 682 ÷ 169.26

4.03x

* Primary Listing of TTK Healthcare.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • TTK Healthcare is overvalued based on assets compared to the IN Pharmaceuticals industry average.
X
Value checks
We assess TTK Healthcare's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. TTK Healthcare has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

TTKHEALTH Future Performance

 How is TTK Healthcare expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover TTK Healthcare, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
6.7%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is TTK Healthcare expected to grow at an attractive rate?
  • TTK Healthcare's earnings growth is positive but not above the low risk savings rate of 7.6%.
Growth vs Market Checks
  • TTK Healthcare's earnings growth is positive but not above the India market average.
  • Unable to compare TTK Healthcare's revenue growth to the India market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
NSEI:TTKHEALTH Future Growth Rates Data Sources
Data Point Source Value (per year)
NSEI:TTKHEALTH Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 6.7%
India Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 20.6%
India Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 13.4%
India Market Earnings Growth Rate Market Cap Weighted Average 18.5%
India Market Revenue Growth Rate Market Cap Weighted Average 11.7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NSEI:TTKHEALTH Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in INR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NSEI:TTKHEALTH Future Estimates Data
Date (Data in INR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
NSEI:TTKHEALTH Past Financials Data
Date (Data in INR Millions) Revenue Cash Flow Net Income *
2018-12-31 6,334 274
2018-09-30 6,313 348
2018-06-30 6,207 393
2018-03-31 5,775 253 182
2017-12-31 5,541 158
2017-09-30 5,126 126
2017-06-30 5,054 93
2017-03-31 5,278 178 187
2016-12-31 5,360 197
2016-09-30 5,399 234
2016-06-30 5,334 236
2016-03-31 5,189 374 227

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • TTK Healthcare's earnings are expected to grow by 6.7% yearly, however this is not considered high growth (20% yearly).
  • Unable to determine if TTK Healthcare is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NSEI:TTKHEALTH Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from TTK Healthcare Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NSEI:TTKHEALTH Future Estimates Data
Date (Data in INR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
NSEI:TTKHEALTH Past Financials Data
Date (Data in INR Millions) EPS *
2018-12-31 14.50
2018-09-30 24.60
2018-06-30 27.83
2018-03-31 12.86
2017-12-31 20.34
2017-09-30 16.18
2017-06-30 11.93
2017-03-31 24.13
2016-12-31 25.37
2016-09-30 30.14
2016-06-30 30.33
2016-03-31 29.19

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if TTK Healthcare will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess TTK Healthcare's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the India market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the India market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
TTK Healthcare has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

TTKHEALTH Past Performance

  How has TTK Healthcare performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare TTK Healthcare's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • TTK Healthcare's year on year earnings growth rate has been positive over the past 5 years.
  • TTK Healthcare's 1-year earnings growth exceeds its 5-year average (73.6% vs 14.7%)
  • TTK Healthcare's earnings growth has exceeded the IN Pharmaceuticals industry average in the past year (73.6% vs 16.4%).
Earnings and Revenue History
TTK Healthcare's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from TTK Healthcare Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NSEI:TTKHEALTH Past Revenue, Cash Flow and Net Income Data
Date (Data in INR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 6,333.83 274.11 2,013.20
2018-09-30 6,312.60 347.76 1,920.26
2018-06-30 6,207.12 393.17 1,894.90
2018-03-31 5,775.47 181.65 1,870.58
2017-12-31 5,540.83 157.94 1,766.50
2017-09-30 5,126.29 125.72 1,616.11
2017-06-30 5,053.73 92.65 893.20
2017-03-31 5,278.06 187.40 1,542.92
2016-12-31 5,360.33 196.94 1,628.97
2016-09-30 5,398.97 234.02 1,646.12
2016-06-30 5,333.56 235.59 1,633.64
2016-03-31 5,188.66 226.65 1,606.44
2015-12-31 5,079.14 212.90 2,243.44
2015-09-30 5,012.12 181.90 2,228.22
2015-06-30 4,918.21 172.50 2,209.00
2015-03-31 4,829.27 161.55 1,538.82
2014-12-31 4,715.93 148.39 2,101.15
2014-09-30 4,565.22 141.41 2,037.67
2014-06-30 4,368.06 139.77 1,949.36
2014-03-31 4,161.80 123.89 1,871.62
2013-12-31 4,016.39 113.83 1,713.83
2013-09-30 3,880.97 109.51 1,667.85
2013-06-30 3,828.58 113.75 1,631.91
2013-03-31 3,822.98 142.03 1,600.28
2012-12-31 3,842.86 156.73 1,474.79
2012-09-30 3,787.95 167.31 1,411.54
2012-06-30 3,697.67 161.07 1,373.56

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • TTK Healthcare has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • TTK Healthcare used its assets less efficiently than the IN Pharmaceuticals industry average last year based on Return on Assets.
  • TTK Healthcare's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess TTK Healthcare's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
TTK Healthcare has a total score of 3/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

TTKHEALTH Health

 How is TTK Healthcare's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up TTK Healthcare's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • TTK Healthcare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • TTK Healthcare's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of TTK Healthcare's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 9.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from TTK Healthcare Company Filings, last reported 3 months ago.

NSEI:TTKHEALTH Past Debt and Equity Data
Date (Data in INR Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 2,392.75 293.76 1,256.87
2018-09-30 2,392.75 293.76 1,256.87
2018-06-30 2,329.74 474.87 1,003.45
2018-03-31 2,329.74 474.87 1,003.45
2017-12-31 1,567.17 222.81 1,040.26
2017-09-30 1,567.17 222.81 1,040.26
2017-06-30 1,508.33 228.73 821.74
2017-03-31 1,574.71 233.24 809.24
2016-12-31 1,463.66 234.89 748.92
2016-09-30 1,463.66 234.89 748.92
2016-06-30 1,362.12 384.82 872.97
2016-03-31 1,362.12 384.82 872.97
2015-12-31 1,276.77 382.92 835.12
2015-09-30 1,276.77 382.92 835.12
2015-06-30 1,182.70 417.13 774.34
2015-03-31 1,182.70 417.13 774.34
2014-12-31 1,142.98 413.78 897.77
2014-09-30 1,142.98 413.78 897.77
2014-06-30 1,069.26 315.01 841.92
2014-03-31 1,069.26 315.01 841.92
2013-12-31 1,038.41 235.05 754.47
2013-09-30 1,038.41 235.05 754.47
2013-06-30 982.22 224.02 845.32
2013-03-31 982.22 224.02 845.32
2012-12-31
2012-09-30
2012-06-30 877.03 182.49 686.71
  • TTK Healthcare's level of debt (12.3%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (22.7% vs 12.3% today).
  • Debt is well covered by operating cash flow (86.1%, greater than 20% of total debt).
  • TTK Healthcare earns more interest than it pays, coverage of interest payments is not a concern.
X
Financial health checks
We assess TTK Healthcare's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. TTK Healthcare has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

TTKHEALTH Dividends

 What is TTK Healthcare's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0.73%
Current annual income from TTK Healthcare dividends.
If you bought ₹2,000 of TTK Healthcare shares you are expected to receive ₹15 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • TTK Healthcare's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.5%).
  • TTK Healthcare's dividend is below the markets top 25% of dividend payers in India (1.93%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NSEI:TTKHEALTH Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
India Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 69 Stocks 0.7%
India Market Average Dividend Yield Market Cap Weighted Average of 1399 Stocks 1.4%
India Minimum Threshold Dividend Yield 10th Percentile 0.3%
India Bottom 25% Dividend Yield 25th Percentile 0.5%
India Top 25% Dividend Yield 75th Percentile 1.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NSEI:TTKHEALTH Future Dividends Estimate Data
Date (Data in ₹) Dividend per Share (annual) Avg. No. Analysts
NSEI:TTKHEALTH Past Annualized Dividends Data
Date (Data in ₹) Dividend per share (annual) Avg. Yield (%)
2018-07-13 5.000 0.636
2018-05-29 5.000 0.628
2017-08-09 5.000 0.563
2017-07-18 5.000 0.644
2017-05-30 5.000 0.645
2016-08-05 5.000 0.565
2015-07-13 4.500 0.471
2015-05-21 4.500 0.467
2014-07-30 4.000 0.473
2014-05-27 4.000 0.621
2013-05-27 4.000 0.773
2012-05-22 4.000 0.949
2011-05-24 4.000 0.929
2010-05-20 3.500 0.906
2009-06-01 3.000 1.520
2009-04-22 3.000 2.924

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been stable in the past 10 years.
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of TTK Healthcare's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (2.9x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess TTK Healthcare's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can TTK Healthcare afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. TTK Healthcare has a total score of 4/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

TTKHEALTH Management

 What is the CEO of TTK Healthcare's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
T. Raghunathan
COMPENSATION ₹15,881,902
AGE 66
TENURE AS CEO 4.7 years
CEO Bio

Mr. T. T. Raghunathan, B.Com., has been the Chief Executive Officer of TTK Healthcare Limited since August 22, 2014. Mr. Raghunathan has been Managing Director of TTK - LIG Ltd., since February 01, 2013. Mr. Raghunathan is a Promoter of Ttk Prestige Ltd. Mr. Raghunathan served as Managing Director of TTK Tantex Limited until February 01, 2013. He has been the Executive Vice Chairman of TTK Healthcare Limited since November 1, 2001. He serves as Non-Executive Vice Chairman of Ttk Prestige Ltd. and has been its Non-Executive Director since 1995. He serves as a Director of TTK Healthcare TPA Pvt. Ltd. Mr. Raghunathan serves as a Director of TTK-LIG Limited, SSL-TTK Limited, TTK Healthcare Services Private Limited and TTK Services (P) Limited. He has been a Director of TTK Healthcare Limited since 1998. He was a Director of TTK Tantex Ltd. He is a Commerce Graduate.

CEO Compensation
  • T.'s compensation has been consistent with company performance over the past year.
  • T.'s remuneration is higher than average for companies of similar size in India.
Management Team

T. Raghunathan

TITLE
Executive Vice Chairman & CEO
COMPENSATION
₹16M
AGE
66
TENURE
4.7 yrs

B. V. K. Prasad

TITLE
Senior VP of Finance & CFO
COMPENSATION
₹7M
AGE
57
TENURE
4.7 yrs

S. Kalyanaraman

TITLE
Whole Time Secretary
COMPENSATION
₹9M
AGE
55

S. Rao

TITLE
Senior Vice President of Business Development - Foods
AGE
53

K. Sunil

TITLE
Senior Vice President of Heart Valve
AGE
55

R. Saranyan

TITLE
President of Protective Devices Division
COMPENSATION
₹4M

Yogesh Yadav

TITLE
Vice President of National Sales - CPD
AGE
51

D. Parthasarthy

TITLE
Senior Vice President of Sales & Marketing - EPD
COMPENSATION
₹5M
AGE
65

Surinder Sharma

TITLE
Head of Strategy & Business Development/NPD - EPD
AGE
54

K. Sankar

TITLE
Vice President of Sales & Marketing - AWD
COMPENSATION
₹4M
AGE
62
Board of Directors Tenure

Average tenure and age of the TTK Healthcare board of directors in years:

4.7
Average Tenure
65.5
Average Age
  • The tenure for the TTK Healthcare board of directors is about average.
Board of Directors

T. Jagannathan

TITLE
Chairman
COMPENSATION
₹120K
AGE
69

T. Raghunathan

TITLE
Executive Vice Chairman & CEO
COMPENSATION
₹16M
AGE
66
TENURE
17.4 yrs

S. Kalyanaraman

TITLE
Whole Time Secretary
COMPENSATION
₹9M
AGE
55
TENURE
4.6 yrs

K. Shankaran

TITLE
Non-Independent Director
COMPENSATION
₹280K
AGE
65
TENURE
19.3 yrs

B. Bhagwat

TITLE
Independent Director
COMPENSATION
₹160K
TENURE
19.3 yrs

Girish Rao

TITLE
Independent Non-Executive Director
COMPENSATION
₹260K
TENURE
4.7 yrs

R. Tulshan

TITLE
Non-Independent Non-Executive Director
COMPENSATION
₹120K

Vandana Walvekar

TITLE
Independent Director
COMPENSATION
₹80K
TENURE
4.7 yrs

S. Balasubramanian

TITLE
Independent Director
COMPENSATION
₹120K
TENURE
4.1 yrs

N. Rajan

TITLE
Independent Non-Executive Director
COMPENSATION
₹80K
TENURE
3.2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (₹) Value (₹)
04. Dec 18 Sell Sanjeev Rawat Individual 27. Nov 18 30. Nov 18 -1,800 ₹769.05 ₹-1,368,077
X
Management checks
We assess TTK Healthcare's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. TTK Healthcare has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

TTKHEALTH News

Simply Wall St News

Is TTK Healthcare Limited's (NSE:TTKHEALTH) High P/E Ratio A Problem For Investors?

This article is written for those who want to get better at using price to earnings ratios (P/E ratios). … TTK Healthcare has a price to earnings ratio of 46.97, based on the last twelve months. … Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS)

Simply Wall St -

Those Who Purchased TTK Healthcare (NSE:TTKHEALTH) Shares A Year Ago Have A 41% Loss To Show For It

Unfortunately the TTK Healthcare Limited (NSE:TTKHEALTH) share price slid 41% over twelve months. … One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. … This reduction in EPS is not as bad as the 41% share price fall.

Simply Wall St -

Is TTK Healthcare Limited's (NSE:TTKHEALTH) 11% Better Than Average?

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. … One way to conceptualize this, is that for each ₹1 of shareholders' equity it has, the company made ₹0.11 in profit. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

Could TTK Healthcare Limited's (NSE:TTKHEALTH) Investor Composition Influence The Stock Price?

Every investor in TTK Healthcare Limited (NSE:TTKHEALTH) should be aware of the most powerful shareholder groups. … TTK Healthcare is a smaller company with a market capitalization of ₹10b, so it may still be flying under the radar of many institutional investors. … Our analysis of the ownership of the company, below, shows that.

Simply Wall St -

Does TTK Healthcare Limited's (NSE:TTKHEALTH) CEO Pay Compare Well With Peers?

First, this article will compare CEO compensation with compensation at similar sized companies. … Raghunathan's Compensation Compare With Similar Sized Companies. … At the time of writing our data says that TTK Healthcare Limited has a market cap of ₹11b, and is paying total annual CEO compensation of ₹16m?

Simply Wall St -

Do Insiders Own Lots Of Shares In TTK Healthcare Limited (NSE:TTKHEALTH)?

The big shareholder groups in TTK Healthcare Limited (NSE:TTKHEALTH) have power over the company. … So it's nice to see some insider ownership, because it may suggest that management is owner-oriented. … Taking a look at the our data on the ownership groups (below), it's seems that.

Simply Wall St -

Should You Be Tempted To Sell TTK Healthcare Limited (NSE:TTKHEALTH) At Its Current PE Ratio?

While TTKHEALTH might seem like a stock to avoid or sell if you own it, it is important to understand the assumptions behind the P/E ratio before you make any investment decisions. … I will break down what the P/E ratio is, how to interpret it and what to watch out for … What you need to know about the P/E ratio

Simply Wall St -

What You Must Know About TTK Healthcare Limited's (NSE:TTKHEALTH) Financial Strength

While small-cap stocks, such as TTK Healthcare Limited (NSE:TTKHEALTH) with its market cap of ₹10.49b, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downturn.

Simply Wall St -

Does TTK Healthcare Limited's (NSE:TTKHEALTH) -19.81% Earnings Drop Reflect A Longer Term Trend?

After reading TTK Healthcare Limited's (NSEI:TTKHEALTH) most recent earnings announcement (31 December 2017), I found it useful to look back at how the company has performed in the past and compare this against the latest numbers. … View our latest analysis for TTK Healthcare How Did TTKHEALTH's Recent Performance Stack Up Against Its Past? … For TTK Healthcare, its latest trailing-twelve-month earnings is ₹157.94M, which, against the previous year's figure, has declined by -19.81%.

Simply Wall St -

Are TTK Healthcare Limited's (NSE:TTKHEALTH) Interest Costs Too High?

With this debt repayment, TTKHEALTH's cash and short-term investments stands at ₹821.74M for investing into the business. … Additionally, TTKHEALTH has generated ₹209.98M in operating cash flow during the same period of time, resulting in an operating cash to total debt ratio of 90.03%, signalling that TTKHEALTH’s current level of operating cash is high enough to cover debt. … Next Steps: TTKHEALTH has demonstrated its ability to generate sufficient levels of cash flow, while its debt hovers at a safe level.

Simply Wall St -

TTKHEALTH Company Info

Description

TTK Healthcare Limited engages in the pharmaceuticals, consumer products, medical devices, and food businesses primarily in India. The company’s Pharmaceuticals segment deals in herbal and allopathic formulations in various therapeutic areas for human and veterinary use. This segment also offers delivery care, female healthcare, haematinic, pain management, neurotrophic, gastro intestinal, male and female fertility, nutritional, cardiac care, derma, urinary specialties, and respiratory care products, as well as calcium supplements. Its Consumer Products segment is involved in the marketing of products under its own brands, including EVA range of cosmetics, Good Home range of scrubbers, air fresheners, etc.; and markets and distributes Woodward's Gripewater. The company’s Medical Devices segment manufactures and distributes heart valve prosthesis; and develops orthopedic implants and instruments under the Altius brand name. The Protective Devices segment trades in condoms and related products under the SKORE brand name. Its Foods segment produces and markets potato and cereal based pellets. The company’s Others segment prints and publishes maps and atlases. TTK Healthcare Limited exports its products to the Middle East, Africa, Asia, etc. The company was incorporated in 1958 and is headquartered in Chennai, India. TTK Healthcare Limited is a subsidiary of TT Krishnamachari & Co., Ltd.

Details
Name: TTK Healthcare Limited
TTKHEALTH
Exchange: NSEI
Founded: 1958
₹9,636,887,106
14,130,333
Website: http://www.ttkhealthcare.com
Address: TTK Healthcare Limited
6, Cathedral Road,
Chennai,
Tamil Nadu, 600086,
India
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
BSE 507747 Equity Shares Mumbai Stock Exchange IN INR 28. May 2001
NSEI TTKHEALTH Equity Shares National Stock Exchange of India IN INR 28. May 2001
Number of employees
Current staff
Staff numbers
2,244
TTK Healthcare employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/21 12:54
End of day share price update: 2019/04/18 00:00
Last estimates confirmation: 2017/05/30
Last earnings filing: 2019/01/30
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.